Similar articles

• [Undesirable metabolic effects following the administration of higher doses of fructose and sorbitol].

  Bode JC. Bode JC. Infusionstherapie (1973). 1974 Oct;1(7):558-63. Infusionstherapie (1973). 1974. PMID: 4219393 German. No abstract available.
• [Biochemical considerations of the use of carbohydrates in parenteral feeding].

  Förster H, Hoffmann H. Förster H, et al. Infusionstherapie (1973). 1974 Apr;1(4):265-79. Infusionstherapie (1973). 1974. PMID: 4219372 German. No abstract available.
• Dangers of intravenous fructose and sorbitol.

  Van den Berghe G, Hers HG. Van den Berghe G, et al. Acta Paediatr Belg. 1978 Jul-Sep;31(3):115-23. Acta Paediatr Belg. 1978. PMID: 101018 No abstract available.
• [The sugar substitutes fructose and sorbite: an unnecessary risk in parenteral nutrition].

  Keller U. Keller U. Schweiz Med Wochenschr. 1989 Jan 28;119(4):101-6. Schweiz Med Wochenschr. 1989. PMID: 2493157 Review. German.
• [Repeated perioperative administration of fructose and sorbitol in a female patient with hereditary fructose intolerance [HFI)].

  Sachs M, Asskali F, Förster H, Encke A. Sachs M, et al. Z Ernahrungswiss. 1993 Mar;32(1):56-66. doi: 10.1007/BF01610085. Z Ernahrungswiss. 1993. PMID: 8484270 Review. German.